Komori
Share Issuance and Disposal6090Human Metabolome Technologies,Inc.Information and Communications, Services and Others

Notice Concerning the Disposal of Treasury Shares as Performance-Linked Post-Delivery Restricted Stock Compensation

The Company resolved to dispose of 7,926 treasury shares to 2 eligible directors as performance-linked, post-delivery restricted stock compensation. The disposal price is ¥719 per share, for a total amount of ¥5,698,794.

Worth reading
50Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
7926
Shares
Wording
Definitive
How definitive the wording is.

Details of issuance or disposal

Disposal of treasury shares as performance-based, post-delivery restricted stock compensation

Who receives how much7,926Shares

当社普通株式 7,926株(自己株式)

Directors of the Company (excluding directors who are Audit and Supervisory Committee members and outside directors)2 / 7,926株

The lower thin line represents the existing number of shares to which these shares will be added.

¥719 per share
Total issue value5,698,794Yen
Amount of funds to be raised
払込金額の総額 5,698,794円、差引手取概算額 Not disclosed
Total Stock-Based Compensation
Monetary receivables of up to ¥100 million per year
Conditions on transfer restrictions

Restricted stock is stock awarded as compensation that cannot be sold during a specified period, with the restrictions lifted once the applicable conditions are met.

Transfer restriction period
2025年10月17日から、当社又は子会社の取締役、執行役、取締役を兼務しない執行役員、使用人、顧問、相談役その他これに準ずる地位のいずれの地位をも退任又は退職した直後の時点まで
Conditions for lifting transfer restrictions
任期満了、死亡その他の正当な理由により所定の地位を退任又は退職した場合、譲渡制限期間満了時に本割当株式の全部を解除。組織再編等の場合は取締役会決議により解除することがある。
Reason for acquisition without consideration
譲渡制限期間満了前に正当な理由なく所定の地位を退任又は退職した場合、または譲渡制限期間中に法令違反行為その他本割当契約で定める一定の事由に該当した場合。
Categories and Number of Persons Covered
当社の取締役(監査等委員である取締役及び社外取締役を除く)2名、7,926株
Intended allottee's holding policy
譲渡制限期間中は譲渡、担保権の設定その他の処分を禁止。譲渡制限期間は2025年10月17日から当社又は子会社の所定の地位を退任・退職した直後まで。
Payment date
17 October 2025
Basis for determining the amount to be paid
2025年9月18日の東京証券取引所スタンダード市場における当社普通株式の終値719円。ディスカウント率・プレミアム率の記載なし。
Details of issuance or disposal
ItemDetails
Type of issuance or disposalDisposal of treasury shares as performance-based, post-delivery restricted stock compensation
Number of shares to be issued or disposed of当社普通株式 7,926株(自己株式)
Issue price and disposal price¥719 per share
Total issue value5,698,794円
Amount of funds to be raised払込金額の総額 5,698,794円、差引手取概算額 Not disclosed
Payment date17 October 2025
Intended allotteeName Directors of the Company (excluding directors who are Audit and Supervisory Committee members and outside directors) / Number of Employees 2 / Number of Shares 7,926株
Intended allottee's holding policy譲渡制限期間中は譲渡、担保権の設定その他の処分を禁止。譲渡制限期間は2025年10月17日から当社又は子会社の所定の地位を退任・退職した直後まで。
Basis for determining the amount to be paid2025年9月18日の東京証券取引所スタンダード市場における当社普通株式の終値719円。ディスカウント率・プレミアム率の記載なし。
Transfer restriction period2025年10月17日から、当社又は子会社の取締役、執行役、取締役を兼務しない執行役員、使用人、顧問、相談役その他これに準ずる地位のいずれの地位をも退任又は退職した直後の時点まで
Conditions for lifting transfer restrictions任期満了、死亡その他の正当な理由により所定の地位を退任又は退職した場合、譲渡制限期間満了時に本割当株式の全部を解除。組織再編等の場合は取締役会決議により解除することがある。
Reason for acquisition without consideration譲渡制限期間満了前に正当な理由なく所定の地位を退任又は退職した場合、または譲渡制限期間中に法令違反行為その他本割当契約で定める一定の事由に該当した場合。
Categories and Number of Persons Covered当社の取締役(監査等委員である取締役及び社外取締役を除く)2名、7,926株
Total Stock-Based CompensationMonetary receivables of up to ¥100 million per year
Items this document does not state (14)
Estimated issuance expensesSpecific use of fundsDilution RateTotal number of issued sharesExercise priceExercise periodNumber of Stock Acquisition RightsUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMost recent equity financingMajor shareholders after the offeringImpact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

対象取締役の報酬と会社業績・株式価値との連動性を明確にし、中長期的な業績向上による企業価値の持続的向上へのインセンティブを与えるとともに、株主との価値共有を進めるため。

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Concerning the Disposal of Treasury Shares as Performance-Linked Post-Delivery Restricted Stock Compensation | Human Metabolome Technologies,Inc. (6090) timely disclosure | Komori